Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$448M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$248M |
| 3 |
AGN
Allergan Inc
AGN
|
+$240M |
| 4 |
Apple
AAPL
|
+$223M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$677M |
| 2 |
Intuitive Surgical
ISRG
|
+$501M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$476M |
| 4 |
Crown Castle
CCI
|
+$365M |
| 5 |
Ralph Lauren
RL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Consumer Discretionary | 14.62% |
| 3 | Technology | 10.39% |
| 4 | Communication Services | 9.8% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
ArcelorMittal
MT
$49.5B
| $1.15M | ﹤0.01% |
36,807
-20,094
| -35% | -$603K |
|
602
APA Corp
APA
$13B
| $1.14M | ﹤0.01% |
13,408
-4,843
| -27% | -$402K |
|
603
Alcoa
AA
$11.3B
| $1.13M | ﹤0.01% |
58,095
-4,870
| -8% | -$94.2K |
|
|
IPHI
604
DELISTED
INPHI CORPORATION
IPHI
| $1.11M | ﹤0.01% |
82,773
-45
| -0.1% | -$546 |
|
605
Plexus
PLXS
$6.43B
| $1.1M | ﹤0.01% |
29,532
+19,091
| +183% | +$650K |
|
|
TBI
606
Trueblue
TBI
$227M
| $1.08M | ﹤0.01% |
44,829
+26,699
| +147% | +$667K |
|
607
Allegiant Air
ALGT
$2.57B
| $1.05M | ﹤0.01% |
9,942
-4,941
| -33% | -$488K |
|
608
B&G Foods
BGS
$303M
| $1M | ﹤0.01% |
28,993
-27,760
| -49% | -$966K |
|
|
DNB
609
DELISTED
Dun & Bradstreet
DNB
| $997K | ﹤0.01% |
9,601
-153
| -2% | -$15.9K |
|
610
Murphy Oil
MUR
$5.55B
| $996K | ﹤0.01% |
16,509
-12,596
| -43% | -$742K |
|
|
WCN
611
Waste Connections
WCN
$43.6B
| $946K | ﹤0.01% |
31,236
-979,403
| -97% | -$28.3M |
|
612
Zimmer Biomet
ZBH
$18.8B
| $946K | ﹤0.01% |
+11,863
| New | +$934K |
|
|
PVTB
613
DELISTED
PrivateBancorp Inc
PVTB
| $942K | ﹤0.01% |
44,034
+13,970
| +46% | +$320K |
|
614
G-III Apparel Group
GIII
$1.54B
| $920K | ﹤0.01% |
33,700
+364
| +1% | +$9.27K |
|
615
Wabtec
WAB
$49.3B
| $911K | ﹤0.01% |
14,498
-224
| -2% | -$13.1K |
|
|
HF
616
DELISTED
HFF Inc.
HF
| $907K | ﹤0.01% |
38,590
-42,311
| -52% | -$864K |
|
617
West Pharmaceutical
WST
$23.7B
| $906K | ﹤0.01% |
22,016
-350
| -2% | -$13.4K |
|
|
TGI
618
DELISTED
Triumph Group
TGI
| $890K | ﹤0.01% |
12,680
-200
| -2% | -$15.4K |
|
619
DHI Group
DHX
$177M
| $876K | ﹤0.01% |
102,899
+40,084
| +64% | +$353K |
|
620
Target
TGT
$66.3B
| $870K | ﹤0.01% |
13,600
+6,101
| +81% | +$415K |
|
|
NAVG
621
DELISTED
Navigators Group Inc
NAVG
| $858K | ﹤0.01% |
29,706
+40
| +0.1% | +$1.15K |
|
|
HCC
622
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $856K | ﹤0.01% |
19,544
+7,925
| +68% | +$349K |
|
|
CNVR
623
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $854K | ﹤0.01% |
40,971
+15,322
| +60% | +$348K |
|
624
Plus Therapeutics
PSTV
$25M
| – | – |
0
| – | – |
|
625
Darling Ingredients
DAR
$9.32B
| $840K | ﹤0.01% |
39,688
+24,152
| +155% | +$492K |
|
Similar funds
Jennison Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Jennison Associates held 756 positions worth $95.4B, up 7.3% from $88.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates withdrew a net $3.46B in Q3 2013, closing 76 positions and reducing 326 holdings. Its most notable exit was Intuitive Surgical, an estimated $501M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Jennison Associates opened a new position in Under Armour worth $157M.
- Jennison Associates's largest Q3 2013 buy was Under Armour: 7,942,523 shares worth $157M.
- Jennison Associates added most to Capri Holdings in Q3 2013, an estimated $448M increase.
- Jennison Associates's biggest Q3 2013 reduction was IBM, cutting an estimated $677M.
- Jennison Associates fully exited Intuitive Surgical in Q3 2013, selling an estimated $501M.
- Jennison Associates's ten largest holdings make up 19% of its $95.4B portfolio in Q3 2013.
- Jennison Associates opened 84 new positions and closed 76 in Q3 2013.
- Jennison Associates's portfolio value rose 7.3% quarter-over-quarter to $95.4B.
Based on Jennison Associates's 13F filing for Q3 2013, filed 13 Nov 2013.